Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

GLP-1s' Effects on Cancer Risk May Be Influenced by Diabetes Severity

(MedPage Today) -- Diabetic patients treated with GLP-1 receptor agonists had a lower cancer risk versus insulin and sulfonylureas but not other diabetes medications, although the benefits varied by diabetes severity, a large cohort analysis with...

GLP-1s' Effects on Cancer Risk May Be Influenced by Diabetes Severity

We haven't written up this one. MedPage Today has the full story — the link below goes straight to it.

Read the original at medpagetoday.com →

More in Health & Medicine

More from Thursday 5 November →